Your browser doesn't support javascript.
loading
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.
König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; Pless, M; Früh, M.
Afiliación
  • König D; Department of Medical Oncology, University Hospital of Basel, Basel, Switzerland. Electronic address: david.koenig@usb.ch.
  • Schär S; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Vuong D; Department of Radiation Oncology, University Hospital of Zurich, Zurich, Switzerland.
  • Guckenberger M; Department of Radiation Oncology, University Hospital of Zurich, Zurich, Switzerland.
  • Furrer K; Department of Thoracic Surgery, University Hospital of Zurich, Zurich, Switzerland.
  • Opitz I; Department of Thoracic Surgery, University Hospital of Zurich, Zurich, Switzerland.
  • Weder W; Clinics for Thoracic Surgery, Bethanien, Zurich, Switzerland.
  • Rothschild SI; Department of Medical Oncology, University Hospital of Basel, Basel, Switzerland.
  • Ochsenbein A; Department of Medical Oncology, University Hospital of Bern (Inselspital), Bern, Switzerland.
  • Zippelius A; Department of Medical Oncology, University Hospital of Basel, Basel, Switzerland.
  • Addeo A; Department of Oncology, University Hospital of Geneva, Geneva, Switzerland.
  • Mark M; Department of Oncology, Cantonal Hospital of Graubünden, Chur, Switzerland.
  • Eboulet EI; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Hayoz S; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Thierstein S; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Betticher DC; Clinics of Medical Oncology, Cantonal Hospital of Fribourg (HFR), Fribourg, Switzerland.
  • Ris HB; Clinics for Thoracic Surgery, Hôpital du Valais, Sion, Switzerland.
  • Stupp R; Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.
  • Curioni-Fontecedro A; Department of Medical Oncology, University Hospital of Zurich, Zurich, Switzerland.
  • Peters S; Department of Medical Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Pless M; Department of Medical Oncology, Cantonal Hospital of Winterthur, Winterthur, Switzerland.
  • Früh M; Department of Medical Oncology/Hematology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.
ESMO Open ; 7(2): 100455, 2022 04.
Article en En | MEDLINE | ID: mdl-35398718
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido